Craniopharyngioma

被引:99
作者
Jane Jr. J.A. [1 ]
Laws E.R. [1 ]
机构
[1] School of Medicine, University of Virginia, Charlottesville
关键词
Craniopharyngioma; Pituitary; Transsphenoidal surgery;
D O I
10.1007/s11102-006-0413-8
中图分类号
学科分类号
摘要
Craniopharyngiomas are benign tumors of the parasellar region. These tumors may be cystic, solid, or combinations of the two. They have a bimodal age distribution and no apparent gender predilection. Patients may present with endocrinopathy or symptoms related to mass effect from the growing tumor. Patients require a multidisciplinary approach during their diagnostic evaluation and subsequent to initiating therapy. Endocrinopathy should be recognized and treated with appropriate hormonal replacement. Surgery is the first-line therapy for most paients. The specific surgical approach must be tailored to the specific clinical situation and depends on the patient age, endocrine status, and the geometry and consistency of the tumor. Whereas most solid tumors will require craniotomy or transsphenoidal surgery, some cystic tumors may be adequately managed with intracavitary therapies. Subtotally resected or residual tumors often require adjuvant radiation therapy or radiosugery. Long-term multidisciplinary follow-up is necessary for all patients. © Springer Science + Business Media, LLC 2006.
引用
收藏
页码:323 / 326
页数:3
相关论文
共 23 条
[1]  
Bunin G.R., Surawicz T.S., Witman P.A., Preston-Martin S., Davis F., Bruner J.M., The descriptive epidemiology of craniopharyngioma, J Neurosurg, 89, pp. 547-551, (1998)
[2]  
Chakrabarti I., Amar A.P., Couldwell W., Weiss M.H., Long-term neurological, visual, and endocrine outcomes following transnasal resection of craniopharyngioma, J Neurosurg, 102, 4, pp. 650-657, (2005)
[3]  
Duff J.M., Meyer F.B., Ilstrup D.M., Laws Jr. E.R., Scleck C.D., Scheithauer B.W., Long-term outcomes for surgically resected craniopharyngiomas, Neurosurg, 46, 2, pp. 291-305, (2000)
[4]  
Fahlbusch R., Honegger J., Paulus W., Huk W., Buchfelder M., Surgical treatment of craniopharyngiomas: Experience with 168 patients, J Neurosurg, 90, 2, pp. 237-250, (1999)
[5]  
Hasegawa T., Kondziolka D., Hadjipanayis C.G., Lunsford L.D., Management of cystic craniopharyngiomas with phosphorus-32 intracavitary irradiation, Neurosurgery, 54, 4, pp. 813-820, (2004)
[6]  
Hoffman H.J., de Silva M., Humphreys R.P., Drake J.M., Smith M.L., Blaser S.I., Aggressive surgical management of craniopharyngiomas in children, J Neurosurg, 76, 1, pp. 47-52, (1992)
[7]  
Honegger J., Buchfelder M., Fahlbusch R., Surgical treatment of craniopharyngiomas: Endocrinological results, J Neurosurg, 90, pp. 251-257, (1999)
[8]  
Karavitaki N., Brufani C., Warner J.T., Adams C.B.T., Richards P., Ansorge O., Shine B., Turner H.E., Wass J.A.H., Craniopharyngiomas in children and adults: Systematic analysis of 121 cases with long-term follow-up, Clin Endo, 62, pp. 397-409, (2005)
[9]  
Kobayashi T., Kida Y., Mori Y., Hasegawa T., Long-term results of gamma knife surgery for the treatment of craniopharyngioma in 98 consecutive cases, J Neurosurg, 103, 6 SUPPL., pp. 482-488, (2005)
[10]  
Laws Jr. E.R., Transsphenoidal microsurgery in the management of craniopharyngioma, J Neurosurg, 52, 5, pp. 661-666, (1980)